$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Oct 23, 2025)
$6.05B
Market Cap
-
P/E Ratio
-5.4
EPS
$78.48
52 Week High
$30.04
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Crispr Therapeutics AG (CRSP) is a pioneering gene editing company leveraging its proprietary CRISPR/Cas9 technology to develop breakthrough therapies for serious genetic disorders, such as sickle cell disease and beta-thalassemia. Based in Zug, Switzerland, the company is actively expanding its clinical pipeline and forging strategic collaborations to translate its innovative science into effective treatments. With a robust portfolio and a commitment to improving patient outcomes, Crispr Therapeutics is positioned as a leader in the evolving biopharmaceutical industry, aiming to redefine the landscape of medicine through advanced gene editing solutions.
YYAI
BYND
SCNX
VHAI
F
CGBS
AIRE
RGTI
VTYX
TSLA
QBTS
RIG
NOK
ADAP
MSAI
T
NVDA
AAL
SOFI
AREB
BITF
IONQ
DNN
PLUG
INTC
SMCI
TLRY
GRAB
MARA
CAN
RF
QS
VZ
JOBY
RXRX
LAES
PLTR
BTBT
DVLT
VLY
AMD
AMC
CIFR
WBD
PFE
UUUU
SOUN
NIO
NVTS
IREN
NEHC
RR
EONR
KMI
HPE
DNUT
KLG
SCWO
HOOD
PBR
LUV
APLD
SNAP
VALE
EPWK
NMRA
YYAI
BYND
SCNX
VHAI
F
CGBS
AIRE
RGTI
VTYX
TSLA
QBTS
RIG
NOK
ADAP
MSAI
T
NVDA
AAL
SOFI
AREB
BITF
IONQ
DNN
PLUG
INTC
SMCI
TLRY
GRAB
MARA
CAN
RF
QS
VZ
JOBY
RXRX
LAES
PLTR
BTBT
DVLT
VLY
AMD
AMC
CIFR
WBD
PFE
UUUU
SOUN
NIO
NVTS
IREN
NEHC
RR
EONR
KMI
HPE
DNUT
KLG
SCWO
HOOD
PBR
LUV
APLD
SNAP
VALE
EPWK
NMRA